© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
Statin use linked with better outcomes in patients starting ADT for prostate cancer
Urology Times staff
Urology Times staff
“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.
In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.
More videos:
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
Related Content:
